Jiangsu Hengrui Pharmaceuticals Co Ltd
Jiangsu Hengrui Pharmaceuticals's GHG Emissions Data Preview
In 2024, Jiangsu Hengrui Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Jiangsu Hengrui Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Jiangsu Hengrui Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jiangsu Hengrui Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Jiangsu Hengrui Pharmaceuticals's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Jiangsu Hengrui Pharmaceuticals amounted to 257,897.24 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Jiangsu Hengrui Pharmaceuticals increased by 23.82%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Jiangsu Hengrui Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Jiangsu Hengrui Pharmaceuticals's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Jiangsu Hengrui Pharmaceuticals were 8,516.6 metric tons of CO₂ equivalent (tCO₂e). a
Has Jiangsu Hengrui Pharmaceuticals reduced its Scope 1 emissions over time?
Since 2021, Jiangsu Hengrui Pharmaceuticals's Scope 1 emissions have decreased by 3.63%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Jiangsu Hengrui Pharmaceuticals's Scope 1 emissions increased by 73.88%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Jiangsu Hengrui Pharmaceuticals's Scope 2 emissions?
In 2024, Jiangsu Hengrui Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 249,380.64 tCO₂e without specifying the calculation method. a
Has Jiangsu Hengrui Pharmaceuticals reduced its Scope 2 emissions over time?
Since 2021, Jiangsu Hengrui Pharmaceuticals's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Jiangsu Hengrui Pharmaceuticals 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2023), Jiangsu Hengrui Pharmaceuticals's Scope 2 emissions (Unspecified Calculation Method) rose by 22.62% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Jiangsu Hengrui Pharmaceuticals use for Scope 2 reporting?
In 2024, Jiangsu Hengrui Pharmaceuticals reported its Scope 2 emissions using an unspecified methodology. a
Jiangsu Hengrui Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Jiangsu Hengrui Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Jiangsu Hengrui Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 8,516.6 tCO₂e and total revenues of USD 3,835 millions. This translates into an emissions intensity of 2.22 tCO₂e per millions USD. a
Jiangsu Hengrui Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Jiangsu Hengrui Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2024, Jiangsu Hengrui Pharmaceuticals reported a Scope 1 emissions intensity of 2.22 tCO₂e per millions USD. Compared to the peer group median of 4.99 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Jiangsu Hengrui Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2024, Jiangsu Hengrui Pharmaceuticals ranked 10 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Jiangsu Hengrui Pharmaceuticals is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a